These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 7295626)
1. Effects of long-term treatment with timolol on lacrimal gland function. Coakes RL; Mackie IA; Seal DV Br J Ophthalmol; 1981 Sep; 65(9):603-5. PubMed ID: 7295626 [TBL] [Abstract][Full Text] [Related]
2. Lysozyme, alfa-1-antitrypsin and serum albumin in tear fluid of timolol treated glaucoma patients with and without symptoms of dry eyes. Nielsen NV; Prause JU; Eriksen JS Acta Ophthalmol (Copenh); 1981 Aug; 59(4):503-9. PubMed ID: 6976056 [TBL] [Abstract][Full Text] [Related]
4. Effects of timolol maleate on tear flow in human eyes. Bonomi L; Zavarise G; Noya E; Michieletto S Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1980; 213(1):19-22. PubMed ID: 6906142 [TBL] [Abstract][Full Text] [Related]
5. The influence of long-term treatment with timolol on human tear lysozyme albumin content. Strasser G; Grabner G Graefes Arch Clin Exp Ophthalmol; 1982; 218(2):93-5. PubMed ID: 7075967 [TBL] [Abstract][Full Text] [Related]
6. Separate and combined effects of timolol maleate and acetazolamide in open-angle glaucoma. Berson FG; Epstein DL Am J Ophthalmol; 1981 Dec; 92(6):788-91. PubMed ID: 7315930 [TBL] [Abstract][Full Text] [Related]
7. [Mid-term results of a double-blind study comparing metipranolol to timolol in the treatment of primary open-angle glaucoma]. Ecoffet M; Demailly P J Fr Ophtalmol; 1987; 10(6-7):451-4. PubMed ID: 2891740 [TBL] [Abstract][Full Text] [Related]
8. Beta-adrenergic receptor blocking drugs: tear lysozyme and immunological screening for adverse reaction. Mackie IA; Seal DV; Pescod JM Br J Ophthalmol; 1977 May; 61(5):354-9. PubMed ID: 17431 [TBL] [Abstract][Full Text] [Related]
9. Role of the beta-adrenergic receptor-binding agent 'timolol' in the treatment of open-angle glaucoma. Strempel I Ophthalmologica; 1982; 184(4):198-203. PubMed ID: 6122193 [TBL] [Abstract][Full Text] [Related]
10. [Results of the use of Thymoptik (timolol) in the treatment of primary glaucoma]. Ermakova VN Vestn Oftalmol; 1981; (5):10-3. PubMed ID: 7303348 [No Abstract] [Full Text] [Related]
11. [Results of long-term treatment of glaucoma with timolol ophthalmic solution (author's transl)]. Merté HJ; Merkle W Klin Monbl Augenheilkd; 1980 Nov; 177(5):562-71. PubMed ID: 7019560 [TBL] [Abstract][Full Text] [Related]
12. [A follow-up study on the intraocular pressure response of timolol eye drops (author's transl)]. Krieglstein GK Klin Monbl Augenheilkd; 1979 Nov; 175(5):627-33. PubMed ID: 547090 [TBL] [Abstract][Full Text] [Related]
13. [Pressure lowering effect and side effects of 0.5% and 1.0% levobunolol eyedrops, compared with 0.5% timolol eyedrops in patients with open-angle glaucoma]. Stryz JR; Merté HJ Klin Monbl Augenheilkd; 1985 Dec; 187(6):537-44. PubMed ID: 3912600 [TBL] [Abstract][Full Text] [Related]
14. [Long-term therapy with timolol for three years (author's transl)]. Urner-Bloch U; Bischoff P Klin Monbl Augenheilkd; 1981 Jul; 179(1):45-7. PubMed ID: 6792420 [TBL] [Abstract][Full Text] [Related]
15. [Tolerance and pharmacologic effectiveness of antiglaucoma eyedrops]. Flury H; Tournoux A; Martenet AC Klin Monbl Augenheilkd; 1986 Jun; 188(6):573-5. PubMed ID: 3761959 [TBL] [Abstract][Full Text] [Related]
17. In vivo confocal microscopy of conjunctiva in preservative-free timolol 0.1% gel formulation therapy for glaucoma. Frezzotti P; Fogagnolo P; Haka G; Motolese I; Iester M; Bagaglia SA; Mittica P; Menicacci C; Rossetti L; Motolese E Acta Ophthalmol; 2014 Mar; 92(2):e133-40. PubMed ID: 24020826 [TBL] [Abstract][Full Text] [Related]
18. [Experiences in a double-blind study with different concentrations of timolol and pilocarpine (author's transl)]. Merté HJ; Merkle W Klin Monbl Augenheilkd; 1980 Oct; 177(4):443-50. PubMed ID: 7019558 [TBL] [Abstract][Full Text] [Related]
19. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma. Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213 [TBL] [Abstract][Full Text] [Related]
20. Two blind randomized cross-over trials in the treatment of primary open angle glaucoma. Mills KB; Hercules B; English M Trans Ophthalmol Soc U K (1962); 1981; 101 (Pt 4)():397-402. PubMed ID: 6764321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]